Deutsche Bank cuts Atai stock rating on Lilly acquisition terms
AI Summary
Deutsche Bank downgraded its stock rating for Atai following terms of Eli Lilly's acquisition of the company. This reflects investor sensitivity to the acquisition deal's implications.